June 3 (Bloomberg) -- Roche Holding AG said its Tarceva medicine kept a form of advanced lung tumor at bay in a late- stage study, the Basel, Switzerland-based company said today in an e-mailed statement.

To contact the editor responsible for this story: Dermot Doherty at ddoherty9@bloomberg.net